Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an ultra-rare autosomal recessive disorder, caused by mutations in SLC37A4 gene. Affected patients present with episodes of fasting hypoglycemia and lactic acidosis, hepatomegaly, growth retardation, hyperlipidemia and renal impairment. In addi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hexner-Erlichman, Zufit, Veiga-da-Cunha, Maria, Zehavi, Yoav, Vadasz, Zahava, Sabag, Adi D., Tatour, Sameh, Spiegel, Ronen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727171/
https://www.ncbi.nlm.nih.gov/pubmed/36507137
http://dx.doi.org/10.3389/fped.2022.1071464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727171/
https://www.ncbi.nlm.nih.gov/pubmed/36507137
http://dx.doi.org/10.3389/fped.2022.1071464

Ejemplares similares